This inventor holds 1 USPTO granted patent. Top assignee: Centre National De La Recherche Scientifique. Active years: 1993.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1993
Title: Lia Prado De Carvalho: Innovator in Benzodiazepine-Receptor Ligands
Introduction
Lia Prado De Carvalho is a distinguished inventor based in Paris, France. She has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds that interact with benzodiazepine receptors. Her innovative work has led to the filing of a patent that showcases her expertise and creativity in this specialized area.
Latest Patents
Lia holds a patent for .beta.-Carboline-derived compounds, which are benzodiazepine-receptor ligands exhibiting inverse agonist and antagonist effects on benzodiazepines. The invention relates to novel compounds of the formulae: ##STR1##, where X can be O, S, or other specified radicals. These compounds are designed to provide new therapeutic options in the treatment of various conditions associated with benzodiazepine receptors. She has 1 patent to her name, reflecting her innovative contributions to the field.
Career Highlights
Lia is affiliated with the Centre National De La Recherche Scientifique, a prominent research institution in France. Her work at this esteemed organization has allowed her to explore and develop her ideas in a collaborative environment. Lia's research focuses on the synthesis and application of benzodiazepine-receptor ligands, which are crucial for advancing pharmacological treatments.
Collaborations
Throughout her career, Lia has collaborated with notable scientists, including Robert H. Dodd and Pierre Potier. These collaborations have enriched her research and contributed to the successful development of her patented compounds.
Conclusion
Lia Prado De Carvalho is a remarkable inventor whose work in benzodiazepine-receptor ligands has the potential to impact the field of medicinal chemistry significantly. Her innovative spirit and dedication to research continue to inspire advancements in therapeutic options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
